The Asia-Pacific oncolytic virotherapy market is experiencing significant growth, driven by advancements in biotechnology and a rising prevalence of cancer across the region. Oncolytic virotherapy, which involves using genetically modified viruses to target and destroy cancer cells while sparing healthy cells, has emerged as a promising cancer treatment. In countries like China, Japan,...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian